Ernesto Paolasso

9.8k total citations · 1 hit paper
19 papers, 2.0k citations indexed

About

Ernesto Paolasso is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ernesto Paolasso has authored 19 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 5 papers in Surgery and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ernesto Paolasso's work include Acute Myocardial Infarction Research (8 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Ernesto Paolasso is often cited by papers focused on Acute Myocardial Infarction Research (8 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Ernesto Paolasso collaborates with scholars based in Argentina, United States and Canada. Ernesto Paolasso's co-authors include Leopoldo Soares Piegas, Rafael Dı́az, Carlos Tajer, Graciela Romero, Jesús Isea, Gabriel I. Barbash, J R Hampton, Michaela Modan, Arni Kristinsson and S Moulopoulos and has published in prestigious journals such as New England Journal of Medicine, Circulation and Diabetes Care.

In The Last Decade

Ernesto Paolasso

19 papers receiving 1.9k citations

Hit Papers

Vorapaxar in the Secondary Prevention of Atherothrombotic... 2012 2026 2016 2021 2012 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ernesto Paolasso Argentina 17 1.5k 469 329 300 274 19 2.0k
Serge Korjian United States 20 1.5k 1.0× 566 1.2× 692 2.1× 204 0.7× 114 0.4× 68 2.2k
Lars Grip Sweden 22 927 0.6× 771 1.6× 171 0.5× 329 1.1× 247 0.9× 72 1.8k
Alon Schaffer Italy 25 950 0.6× 537 1.1× 255 0.8× 210 0.7× 122 0.4× 80 1.8k
Chi‐Tai Kuo Taiwan 27 1.9k 1.3× 298 0.6× 578 1.8× 191 0.6× 186 0.7× 113 2.5k
M. L. Simoons Netherlands 17 1.1k 0.7× 430 0.9× 147 0.4× 183 0.6× 292 1.1× 44 1.4k
Michael Kapeliovich Israel 26 1.3k 0.8× 530 1.1× 103 0.3× 330 1.1× 301 1.1× 49 2.2k
Pierre Théroux Canada 19 1.5k 1.0× 625 1.3× 178 0.5× 83 0.3× 514 1.9× 37 2.0k
David Brosh Israel 21 1.2k 0.8× 650 1.4× 86 0.3× 247 0.8× 449 1.6× 52 2.1k
Annunziata Nusca Italy 18 1.1k 0.7× 954 2.0× 128 0.4× 295 1.0× 339 1.2× 102 2.0k
Kaivan Khavandi United Kingdom 18 976 0.6× 707 1.5× 114 0.3× 180 0.6× 86 0.3× 32 2.2k

Countries citing papers authored by Ernesto Paolasso

Since Specialization
Citations

This map shows the geographic impact of Ernesto Paolasso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ernesto Paolasso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ernesto Paolasso more than expected).

Fields of papers citing papers by Ernesto Paolasso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ernesto Paolasso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ernesto Paolasso. The network helps show where Ernesto Paolasso may publish in the future.

Co-authorship network of co-authors of Ernesto Paolasso

This figure shows the co-authorship network connecting the top 25 collaborators of Ernesto Paolasso. A scholar is included among the top collaborators of Ernesto Paolasso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ernesto Paolasso. Ernesto Paolasso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Paolasso, Ernesto, et al.. (2013). Novel Oral Anticoagulants in Atrial Fibrillation: A Meta‐analysis of Large, Randomized, Controlled Trials vs Warfarin. Clinical Cardiology. 36(2). 61–67. 59 indexed citations
2.
Paolasso, Ernesto, et al.. (2013). Current and new oral antithrombotics in non-valvular atrial fibrillation: a network meta-analysis of 79 808 patients. Heart. 100(5). 396–405. 53 indexed citations
3.
Morrow, David A., Eugene Braunwald, Marc P. Bonaca, et al.. (2012). Vorapaxar in the Secondary Prevention of Atherothrombotic Events. New England Journal of Medicine. 366(15). 1404–1413. 656 indexed citations breakdown →
4.
Eikelboom, John W., Stuart J. Connolly, Peggy Gao, et al.. (2012). Stroke Risk and Efficacy of Apixaban in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease. Journal of Stroke and Cerebrovascular Diseases. 21(6). 429–435. 67 indexed citations
5.
Barzilay, Joshua I., Peggy Gao, Lars Rydén, et al.. (2011). Effects of Telmisartan on Glucose Levels in People at High Risk for Cardiovascular Disease but Free From Diabetes. Diabetes Care. 34(9). 1902–1907. 25 indexed citations
6.
Lamy, André, P.J. Devereaux, Dorairaj Prabhakaran, et al.. (2011). Rationale and design of The Coronary Artery Bypass Grafting Surgery Off or On Pump Revascularization Study: A large international randomized trial in cardiac surgery. American Heart Journal. 163(1). 1–6. 25 indexed citations
7.
Anderson, Craig S., Koon Teo, Peggy Gao, et al.. (2010). Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies. The Lancet Neurology. 10(1). 43–53. 149 indexed citations
8.
Paolasso, Ernesto, et al.. (2009). Culprit‐Only or Multivessel Percutaneous Coronary Stenting in Patients with Non‐ST‐Segment Elevation Acute Coronary Syndromes: One‐Year Follow‐Up. Journal of Interventional Cardiology. 22(4). 329–335. 42 indexed citations
9.
Orlandini, Andrés, Rafael Díaz, Daniel Wojdyla, et al.. (2006). Outcomes of patients in clinical trials with ST-segment elevation myocardial infarction among countries with different gross national incomes. European Heart Journal. 27(5). 527–533. 29 indexed citations
12.
Orlandini, Andrés, et al.. (2000). Usefulness of pharmacologic stress echocardiography in a chest pain center. The American Journal of Cardiology. 86(11). 1247–1250. 14 indexed citations
13.
Hasdai, David, David R. Holmes, Douglas A. Criger, et al.. (2000). Cigarette smoking status and outcome among patients with acute coronary syndromes without persistent ST-segment elevation: Effect of inhibition of platelet glycoprotein IIb/IIIa with eptifibatide. American Heart Journal. 139(3). 454–460. 16 indexed citations
14.
Díaz, Rafael, et al.. (2000). Acute Cardiac Rupture During Dobutamine-Atropine Echocardiography Stress Test. Journal of the American Society of Echocardiography. 13(2). 152–153. 15 indexed citations
15.
Dı́az, Rafael, Ernesto Paolasso, Leopoldo Soares Piegas, et al.. (1998). Metabolic Modulation of Acute Myocardial Infarction. Circulation. 98(21). 2227–2234. 389 indexed citations
16.
Barbash, Gabriel I., H. D. White, Michaela Modan, et al.. (1995). Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.. PubMed. 16(3). 313–6. 112 indexed citations
19.
Paolasso, Ernesto, et al.. (1992). The ridogrel versus aspirin patency trial (rapt). Circulation. 86(4). 642–642. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026